GOVX

Conviction 27HealthcareScan · Thu, Jun 25, 2026

GOVX$1.31-5.43%

ResistanceSupportVol 14

Vol MA14 820.25K

Mar 26Apr 14May 1May 19Jun 8Jun 25

GeoVax Labs, Inc.PHARMACEUTICAL PREPARATIONSwww.geovax.com ↗

Price1.31

Change-5.43%

Gap-4.35%

Rel volume0.25×

Avg volume993.81K

Avg $ vol1.62M

SMA 201.53

SMA 501.58

SMA 2001.24

Price vs 50-17.42%

Price vs 200+5.62%

MA stackmixed

50/200 cross—

Supertrenddown · 2.05

RSI (14)43

MACD hist-0.02

MACD cross—

Stoch %K / %D27 / 23

ADX (14)23

+DI / −DI31 / 24

RSI divergence—

MACD divergence—

ATR %+22.38%

ADR %14.95%

52w high3.64

52w low0.1592

From 52w high-64.15%

Above 52w low+719.72%

New 52w highNo

SqueezeOff

Bollinger width103.98%

%B0.36

Donchian pos10.22%

Donchian high2.93

Donchian low1.12

AVWAP (52w high)2.79

vs AVWAP high-53.25%

AVWAP (52w low)2.25

vs AVWAP low-42.04%

OBV trendDown

Chaikin MF (20)-0.38

Today vs 20d0.25×

Avg vol (14d)820.25K

Avg vol (20d)993.81K

Avg $ vol (20d)1.62M

Market cap4.53M

RS 3m (vs SPY)-22.65%

RS 6m (vs SPY)+759.10%

RS line new highNo

Trend template4/8

Technical rank53.2

1 week+10.59%

1 month-62.61%

3 months-13.00%

6 months+657.40%

1 year+44.68%

YTD+530.43%

P/E-0.21

P/B9.18

P/S1.82

P/FCF-0.21

EPS-3.04

Div yield—

ROE—

ROA—

Debt/Eq—

Current1.06

EV/EBITDA-0.15

Gross margin—

Net margin-862.34%

Rev growth-37.06%

EPS growth14.11%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value3.26M

Revenue0

Net income-5.26M

Gross profit—

Free cash flow-21.5M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out5.21M

Employees19

ListedWed, Feb 1, 1995

Free float43.06M

Float %99.4%

Short interest584.47K

Days to cover0.0d

Short volume35.8%

Squeeze score3 / 100

Next earningsMon, Jul 27, 2026 (32d)

EPS forecast−$2.15 · 2 est

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction27 / 100

Pattern quality—

Tech rank53.2 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance4.35

Support1.12

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in GOVX

All disclosures →

No recent disclosed trades by Congress in GOVX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in GOVX · 10 buys

Insider	Side	Shares	Value	Traded	Filed
Morgan Jayne Director · Stock Option · 2026-06-17	Grant	6K	—	2026-06-17	2026-06-22
SPENCER JOHN N JR Director · Stock Option · 2026-06-17	Grant	6K	—	2026-06-17	2026-06-22
Kollintzas Dean G Director · Stock Option · 2026-06-17	Grant	6K	—	2026-06-17	2026-06-22
Lemerond Nicole Director · Stock Option · 2026-06-17	Grant	6K	—	2026-06-17	2026-06-22
CHASE RANDAL D Director · Stock Option · 2026-06-17	Grant	6K	—	2026-06-17	2026-06-22
McKee Kelly T. Jr. Chief Medical Officer · Stock Option · 2026-06-17	Grant	17.6K	—	2026-06-17	2026-06-22
NEWMAN MARK J Chief Scientific Officer · Stock Option · 2026-06-17	Grant	17.6K	—	2026-06-17	2026-06-22
Reynolds Mark CFO · Stock Option · 2026-06-17	Grant	17.6K	—	2026-06-17	2026-06-22
MCNALLY ROBERT T Director · Stock Option · 2026-06-17	Grant	6K	—	2026-06-17	2026-06-22
DODD DAVID A President, CEO · Stock Option · 2026-06-17	Grant	29.3K	—	2026-06-17	2026-06-22

SEC filings

EDGAR filings in GOVX · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.